Side-by-side financials for ETON and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ETON | NVS |
|---|---|---|
| Market cap | - | $293.12 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $79.95M | - |
| Net income (latest FY) | -$4.60M | - |
| Net margin | -5.8% | - |
| SEC filings | 371 | 947 |
Full pages: Eton Pharmaceuticals, Inc. and Novartis AG, or browse the full rankings.